News for XENT Stock

Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization Orthofix Announces Appointment of Thomas A. West to Board of Directors Intersect ENT Reports Third Quarter 2021 Financial Results First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe Intersect ENT Reports Second Quarter 2021 Financial Results Medtronic to Acquire Intersect ENT U.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis Intersect ENT to Report Second Quarter 2021 Financial Results on August 6 Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery Intersect ENT Reports First Quarter 2021 Financial Results Intersect ENT to Participate at Upcoming Investor Conferences Intersect ENT Announces Appointment of New Vice President of Sales Intersect ENT Announces Date Change for First Quarter 2021 Financial Results Announcement EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation Intersect ENT to Report First Quarter 2021 Financial Results Intersect ENT Announces Changes to its Board of Directors Dr. Neil Hattangadi Joins Intersect ENT’s Board of Directors Intersect ENT to Participate at the Oppenheimer 31st Annual Healthcare Conference Intersect ENT Reports Fourth Quarter and Full Year 2020 Financial Results CMS Consolidates SINUVA Sinus Implant Coverage Under a Distinct Code, J7402, and Publishes an ASP Clarifying Payment and Easing Payer Coverage Adjudication Intersect ENT to Report Fourth Quarter and Full Year 2020 Financial Results Intersect ENT Announces Launch of the New Straight Delivery System Packaged with the PROPEL® Mini Sinus Implant Intersect ENT to Participate in Upcoming Investor Conferences Intersect ENT Announces CMS Approval of Coding Application for PROPEL® Sinus Implant Intersect ENT Announces Preliminary Revenue for Fourth Quarter of 2020 CORRECTING and REPLACING - Intersect ENT to Present at the 39th Annual J.P. Morgan Healthcare Conference Intersect ENT to Present at the 39th Annual J.P. Morgan Healthcare Conference Intersect ENT Announces New Appointments to Executive Leadership Team Intersect ENT Reports Third Quarter 2020 Financial Results Intersect ENT Announces Preliminary Revenue for Third Quarter of 2020 Intersect ENT to Report Third Quarter 2020 Financial Results Intersect ENT Closes Acquisition of Fiagon AG Medical Technologies